Some experts say the world is on the cusp of a “golden age” of genomics, when a look at the DNA code will reveal your risk of cancer, diabetes or heart disease, and predict which drugs will work for you. Yet the $3 billion international Human Genome Project, whose first phase was completed a decade ago, has not led to a single blockbuster diagnosis or product.

Half way through this article you’ll come to a discussion of the UK Biobank. Perhaps health insurance reform in the US is taking us to a time and place when such a research project is feasible on this side of the Atlantic too.

Leave a Reply

Your email address will not be published. Required fields are marked *